Dexcom (DXCM) Deferred Taxes (2010 - 2026)

Dexcom (DXCM) has 16 years of Deferred Taxes data on file, last reported at $7.3 million in Q1 2026.

• On a quarterly basis, Deferred Taxes rose 225.86% year-over-year to $7.3 million in Q1 2026; TTM through Mar 2026 was $195.3 million, a 358.33% increase from a year earlier, with the FY2025 full-year figure at $182.2 million, up 515.98% from the prior year.
• Deferred Taxes for Q1 2026 stood at $7.3 million, down from $78.9 million in the prior quarter.
• Over the last five years, Deferred Taxes for DXCM reached as high as $118.0 million in Q3 2025 and fell as low as -$60.9 million in Q4 2023.
• Historically, Deferred Taxes has averaged $2.0 million across 5 years, with a median of $1.2 million in 2023.
• Across the five-year window, Deferred Taxes sank 3583.33% in 2024 and jumped 1117.24% in 2025, its largest moves.
• Year by year, Deferred Taxes stood at -$19.6 million in 2022, then plunged by 210.71% to -$60.9 million in 2023, then climbed by 28.57% to -$43.5 million in 2024, then jumped by 281.38% to $78.9 million in 2025, then plunged by 90.75% to $7.3 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were $7.3 million in Q1 2026, $78.9 million in Q4 2025, and $118.0 million in Q3 2025.